Dianthus Therapeutics, Inc. (DNTH) compared with its closest peers (COCP, ORMP, SGMT, CYCN, OMER). Peer set by Pharmaceutical Products; 10 comparable drugmakers. First-party data.
Cocrystal Pharma, Oramed Pharmaceuticals, Sagimet Biosciences, Cyclerion Therapeutics, Omeros, Elicio Therapeutics, Atossa Therapeutics, DiaMedica Therapeutics, GeoVax Labs and Veradermics share Dianthus Therapeutics's sub-industry, pharmaceutical makers.
| Company | Market Cap | P/E |
|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | $22.25M | -1.2 |
| Oramed Pharmaceuticals Inc. (ORMP) | $210.48M | 4.1 |
| Sagimet Biosciences Inc. (SGMT) | $584.26M | -3.7 |
| Cyclerion Therapeutics, Inc. (CYCN) | $21.21M | -1.1 |
| Omeros Corporation (OMER) | $1.37B | 131.3 |
| Elicio Therapeutics, Inc. (ELTX) | $68.07M | -3.1 |
| Atossa Therapeutics, Inc. (ATOS) | $24.85M | -0.1 |
| DiaMedica Therapeutics Inc. (DMAC) | $364.54M | -11.4 |
| GeoVax Labs, Inc. (GOVX) | $5.31M | -0.0 |
| Veradermics, Incorporated (MANE) | $4.12B | — |
| Sector P/E (Healthcare) | 21.6 |
| Industry P/E (Pharmaceutical Products) | 17.2 |
DNTH overview · DNTH earnings · DNTH financials · DNTH KPIs · DNTH documents · DNTH ownership
Data sourced from U.S. SEC EDGAR filings and market data. Not personalized investment advice.